Crinetics Pharmaceuticals announces grants made in July 2024 under Nasdaq Listing Rule 5635(c)(4).

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2024, the Compensation Committee of Crinetics’ Board of Directors…

Read More: https://www.globenewswire.com/news-release/2024/07/10/2911491/0/en/Crinetics-Pharmaceuticals-Announces-July-2024-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html